Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan.

The diagram depicts several generations of CAR-T cell modifications. (1) Traditional CAR-T cells are engineered ... the PD-1–blocking scFv secreted by antigen-irrelevant CAR-T cells could bind to ...

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...

Prescient Therapeutics Ltd has resolved the technical difficulties facing its OmniCAR program by creating a new generation of improved variants of the next-generation CAR-cell platform.

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...

Canada Excellence Research Chair in Immunophysiology and Immunotherapy Paul Kubes reflects on progress in research, building a team, and his vision for the future of immunology after his first year at ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases. By selectively depleting CD19-positive B-cells, ...

“There’s an estimated $175 billion sitting in global funds awaiting investment in AI projects, and if the U.S. doesn’t attract those ... s next-generation in-car experience.

In-vivo CAR T-cell generation could potentially reduce manufacturing costs because T cells are directly modified within the patient, eliminating the need for ex vivo processes such as cell collection ...

Congratulations to the babies born into Generation Beta, starting on Jan. 1, 2025. Now, start saving for your retirement. A new Prudential survey asked respondents how much they thought it would ...

In summary, we have successfully developed a CD70-targeting allogeneic CAR-T cell therapy, termed SAP UCAR-T, which demonstrated enhanced in vivo persistence and tumor-eliminating ability ... and the ...